Pharmacology of ribosomal immunotherapy

Drugs

Volumn 54, Issue SUPPL. 1, 1997, Pages 33-36

  Clot, Jacques ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COLONY STIMULATING FACTOR; CYTOKINE; IMMUNOSTIMULATING AGENT; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; OXYGEN RADICAL; PROTEOGLYCAN; RIBOMUNYL; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; BACTERIUM; CELL ADHESION; CELL STIMULATION; CHEMOTAXIS; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOTHERAPY; KLEBSIELLA PNEUMONIAE; LYMPHOCYTE PROLIFERATION; MACROPHAGE; NATURAL KILLER CELL; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; RIBOSOME; SHORT SURVEY; T LYMPHOCYTE; TONSIL; VIRUS INFECTION;

ALPHAVIRUS; ANIMALIA; BACTERIA (MICROORGANISMS); KLEBSIELLA PNEUMONIAE;

EID: 0030799220     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199700541-00009     Document Type: Short Survey

References (17)

1. Faure G, Béné MC. Use of bacterial ribosomal immunostimulators in respiratory tract infections. Clin Immunother 1995; 4 (2): 138-46
2. Dussourd d'Hinterland L, Normier G, Durand I. Ribosomal vaccines: preparation of subcellular fractions. Arzneimittel Forschung 1980; 30: 126-32
3. Gregory RL. Microbial ribosomal vaccines. Rev Infect Dis 1986; 8: 208-17
4. Normier G, Pinel AM, Dussourd d'Hinterland L, et al. Ribosomes as carriers for anligenic determinants of the surface of microorganisms. Dev Biol Stand 1992; 77: 79-85
5. Hbabi L, Roques C, Michel G, et al. In vitro stimulation of polymorphonuclear cell adhesion by Ribomunyl and antibiotic + Ribomunyl combinations: effects on CD18, CD35 and CD16 expression. Int J Immunopharm 1993; 15: 163-73
6. Pujol JL, Klein B, Godard P, et al. Bacterial ribosomal immunostimulants prime alveolar macrophages in viva to produce interleukin 1 in vitro. Chest 1991; 100: 644-8
7. Lini W, De Rossi M, Licciardello L, et al. Chemotactic cytokine gene expression and production induced in human monocytes by membrane proteoglycans from Klebsiella pneumoniae. Int J Immunopharm 1991; 13: 631-7
8. Allavena P, Erroi A, Pirelli A, et al. Stimulation of cytotoxic and non-cytotoxic functions of natural killer cells by bacterial membrane proteoglycans and ribosomes. Inl J Immunopharm 1989; 11: 29-34
9. Millet J, Lafont S, De Fraissinette A, et al. Polyclonal activation of murine B cells by a membrane proteoglycan of Klebsiella pneumoniae. Clin Exp Immunol 1987; 70: 201-8
10. Lafont S, Millet I, Kouassi E, et al. Induction of murine B cell proliferation and immunoglobulin synthesis by some bacterial ribosomes. Microbiol Immunol 1988; 32: 1043-58
11. Fontanges R, Robert D, Content Y, et al. Pouvoir vaccinant de ribosomes extraits de K, pneumoniae, S. pneumoniae, S. pyogenes et H. influenzae et d'une fraction membranaire de K. pneumoniae. Rev Fr Allergol Immunol Clin 1977; 17: 35-81
12. Ménardo JL, Bousquet J, Clavel R, et al. Immunostimulation à visée respiratoire par un vaccin administré par voie orale. Poumon Coeur 1982; 38 (5): 297-300
13. Faure G, Béné MC, Simon C, et al. Increase in specific antibody-forming cells in human lonsils after oral stimulation with D-53, a ribosomal vaccine. Int J Immunopharm 1990; 12: 315-20
14. Zanin C, Perrin P, Béné MC, et al. Antibody-producing cells in peripheral blood and tonsils after oral treatment of children with bacterial ribosomes. Int J Immunopharm 1994; 16: 497-505
15. Hbabi-Haddioui L, Roques C. Inhibition of Streptococcus pneumoniae adhesion by specific salivary IgA after oral immunisation with a ribosomal immunostimulant. Drugs 1997; 54 Suppl. 1: 29-32
16. Millet I, Lafont S, Jeanin M, et al. Proliferative response of human T lymphocyte to a vaccinal preparation of ribosomes from Streptococcus pyogenes. Int Arch Allergy Immunol 1988; 86: 432-5
17. Snapper CM, Mond JJ. LA model for induction of T-cell-independent humoral immunity in response to polysaccharide antigens. J Immunol 1996; 157: 2229-33